Tomsche David Scott's Form 4 filing
Immucell Corp (ICCC) · filed Nov 28, 2025
- Accession no.
- 0001437749-25-036477
- Filed
- Nov 28, 2025
- Trade date
- Nov 25, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $15.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tomsche David ScottCIK 0001384044 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +1,633 | $4.76 | +$7,773.08 | 52,720 | Direct | |
| Nov 25, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +1,633 | $4.77 | +$7,789.41 | 4,740 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.